IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2993
+0.0071 (2.43%)
At close: May 16, 2025, 4:00 PM
0.3000
+0.0007 (0.23%)
After-hours: May 16, 2025, 8:00 PM EDT
IGC Pharma Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for IGC Pharma stock ranges from a low of $3.50 to a high of $4.25. The average analyst price target of $3.88 forecasts a 1,196.36% increase in the stock price over the next year.
Price Target: $3.88 (+1,196.36%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 6, 2025.
Analyst Ratings
The average analyst rating for IGC Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +1,069.40% | Mar 6, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4 → $4.25 | Strong Buy | Maintains | $4 → $4.25 | +1,319.98% | Feb 24, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.75 → $4 | Strong Buy | Maintains | $3.75 → $4 | +1,236.45% | Dec 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +1,152.92% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.25 → $3.5 | Strong Buy | Maintains | $3.25 → $3.5 | +1,069.40% | Jul 29, 2024 |
Financial Forecast
Revenue This Year
1.26M
from 1.35M
Decreased by -6.47%
Revenue Next Year
1.47M
from 1.26M
Increased by 16.45%
EPS This Year
-0.09
from -0.22
EPS Next Year
-0.09
from -0.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.3M | 1.6M | 1.6M |
| Avg | 1.3M | 1.5M | 1.5M |
| Low | 1.2M | 1.4M | 1.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.3% | 25.3% | 7.5% |
| Avg | -6.5% | 16.5% | 3.4% |
| Low | -9.6% | 9.1% | 0.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.07 | -0.07 | -0.09 |
| Avg | -0.09 | -0.09 | -0.09 |
| Low | -0.10 | -0.11 | -0.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.